Item 2.02. Disclosure of Results of Operations and Financial Condition.

On August 5, 2020 we issued the press release attached as Exhibit 99.1. It is incorporated into this report by reference. The press release describes the results of our operations for the quarter and fiscal year ended June 30, 2020.

Item 8.01. Other Events.

On August 5, 2020 we announced that our board of directors declared a quarterly cash dividend of US $0.39 per share. The dividend will have a record date of August 20, 2020, payable on September 24, 2020. The dividend will be paid in U.S. currency to holders of ResMed's common stock trading on the New York Stock Exchange. Holders of Chess Depositary Instruments trading on the Australian Securities Exchange will receive an equivalent amount in Australian currency, based on the exchange rate on the record date, and reflecting the 10:1 ratio between CDIs and NYSE shares. The ex-dividend date will be August 19, 2020 for common stockholders and for CDI holders. ResMed has received a waiver from the ASX's settlement operating rules, which will allow ResMed to defer processing conversions between its common stock and CDI registers from August 19, 2020 through August 20, 2020, inclusive.

Item 9.01. Financial Statements and Exhibits.




(d)  Exhibits



Exhibits:      Description of Document

99.1             Press Release dated August 5, 2020 regarding results of
               operations

104            Cover Page Interactive Data File (embedded within the Inline XBRL,
               document)




                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses